Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 26;62(5):e02424-17.
doi: 10.1128/AAC.02424-17. Print 2018 May.

Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties

Affiliations

Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties

Farhana Mosaddeque et al. Antimicrob Agents Chemother. .

Abstract

The rapid spread of strains of malaria parasites that are resistant to several drugs has threatened global malaria control. Hence, the aim of this study was to predict the antimalarial activity of chemical compounds that possess anti-hemozoin-formation activity as a new means of antimalarial drug discovery. After the initial in vitro anti-hemozoin-formation high-throughput screening (HTS) of 9,600 compounds, a total of 224 hit compounds were identified as hemozoin inhibitors. These 224 compounds were tested for in vitro erythrocytic antimalarial activity at 10 μM by using chloroquine-mefloquine-sensitive Plasmodium falciparum strain 3D7A. Two independent experiments were conducted. The physicochemical properties of the active compounds were extracted from the ChemSpider and SciFinder databases. We analyzed the extracted data by using Bayesian model averaging (BMA). Our findings revealed that lower numbers of S atoms; lower distribution coefficient (log D) values at pH 3, 4, and 5; and higher predicted distribution coefficient (ACD log D) values at pH 7.4 had significant associations with antimalarial activity among compounds that possess anti-hemozoin-formation activity. The BMA model revealed an accuracy of 91.23%. We report new prediction models containing physicochemical properties that shed light on effective chemical groups for synthetic antimalarial compounds and help with in silico screening for novel antimalarial drugs.

Keywords: antimalarial; drug; hemozoin; malaria; prediction.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Workflow of this study. First, 224 compounds that showed antihemozoin activity in our previous study (22) underwent in vitro antimalarial assays at 10 μM. Second, 30 compounds with ≥45% parasite-inhibitory efficacy underwent an in vitro dose-response assay at concentrations of between 0.5 nM and 10 μM. Next, 22 compounds with IC50s of ≤10 μM were identified. Subsequently, the main structures and physicochemical properties of these compounds were searched by using SciFinder. Finally, the prediction models were generated by the traditional approach versus the Bayesian approach, using their physical and chemical properties.
FIG 2
FIG 2
Initial in vitro antimalarial screening of 224 compounds using the chloroquine-mefloquine-sensitive P. falciparum 3D7A strain. The circle dots represent the percentages of parasite inhibition of 224 compounds, including 30 compounds with parasite inhibition values of ≥45%.
FIG 3
FIG 3
Models selected by Bayesian model averaging. Blue and red represent positive and negative variable estimates, respectively, while uncolored variables were not included in the model. On the x axis, models were listed in the order of the declines in the posterior probability.

Similar articles

Cited by

References

    1. World Health Organization. 2016. World malaria report 2015. World Health Organization, Geneva, Switzerland.
    1. Parhizgar A, Tahghighi A. 2017. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran J Med Sci 42:115–128. - PMC - PubMed
    1. Eastman R, Fidock D. 2009. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 7:864–874. doi:10.1038/nrmicro2239. - DOI - PMC - PubMed
    1. Plowe C. 2009. The evolution of drug-resistant malaria. Trans R Soc Trop Med Hyg 103(Suppl 1):S11–S14. doi:10.1016/j.trstmh.2008.11.002. - DOI - PMC - PubMed
    1. Dondorp A, Ringwald P. 2013. Artemisinin resistance is a clear and present danger. Trends Parasitol 29:359–360. doi:10.1016/j.pt.2013.05.005. - DOI - PubMed

LinkOut - more resources